Global efforts in the fight against COVID-19
Latest – new solutions, webinars and updates
NeuMoDx COVID-19 solutions added to the QIAGEN portfolioQIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systems
QIAGEN launches easy-to-use antigen testThe QIAreach SARS-CoV-2 Antigen Test is an digital, easy-to-use solution that can analyze over 30 samples per hour on a portable device.
QIAGEN launches SARS-CoV-2 test for T cell responseQIAGEN to launch QuantiFERON SARS-CoV-2 for research into causes, spread and control of COVID-19 through T cell response
How can we support your lab?
Reach a specialist about SARS-CoV-2 resources.